Search Results for "Recor Renal"
Original Source: ReCor Medical, Inc.
Founded in 2009, ReCor is a private venture-backed, early-stage company developing novel therapeutic ultrasound catheter technology. ReCor is backed by European and U.S. investors including Sofinnova Partners, one of the largest life science investors in Europe. The Companyâs PARADISE⢠technology for renal denervation is CE-marked. For more information about ReCor Medical, please visit the Companyâs website at www.recormedical.com.
Matching Channels
Matching News
ReCor wins EU approval for 2nd-gen renal denervation device
ReCor Medical has been cleared to market a new version of its ultrasound-based renal denervation device, which is used to con -More-
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant...
ReCor Medical Expands Its Medical Advisory Board
Click here for video interviews ReCor Medical announced today that it has expanded its medical advisory board in anticipation of conducting post-market clin...
ReCor Medical announced today that it has commenced a 50-patient, post-market study across multiple sites in Europe with its CE-marked next-generation PARADISE system, a m...
ReCor Medical reported one-year follow-up data on patients who have been treated via renal denervation for their resistant hypertension with the Company’s PARADISE® Syst...
ReCor Medical announced today that it has received CE mark for its next-generation PARADISE system, a minimally invasive 6Fr over-the-wire (OTW) ultrasound device for trea...
Postmarket trial begins for ReCor's hypertension device
ReCor Medical has begun patient enrollment for a postmarket trial of the company's Paradise renal denervation technology, a n -More-
Six-month data from ReCor’s PARADISE System trial on resistant hypertension
ReCor Medical, an emerging medical device company, reported today six-month follow-up data on eight patients who have been treated via renal denervation for their resistant hypertension with the Compa...
Matching PubMed Articles
Aims: To evaluate a novel modality utilising ultrasound for renal denervation designed to reduce the duration of the intervention as well as to increase the consistency of the clinical outcome. Method...
Renal manifestations and complications of inflammatory bowel disease.
Renal manifestations and complications are not rare in patients with inflammatory bowel disease (IBD) and may present as nephrolithiasis, amyloidosis, tubulointerstitial nephritis, and glomerulonephri...
Quantification of BK Viral Load in Asymptomatic Renal Allograft Recipients.
Introduction: Polyoma BK virus (BKV) has recently been identified to cause renal allograft dysfunction, which manifests as polyomavirus-associated nephropathy (PVAN). However, the presence and level o...
Impact of renal function before mechanical circulatory support on posttransplant renal outcomes.
Renal dysfunction is common before mechanical circulatory support (MCS). Mechanical circulatory support frequently improves renal function, but the impact of pre-MCS renal dysfunction on renal functio...
Renal Microvascular Disease Predicts Renal Function in Diabetes.
Abstract Renal microvascular disease reflected directly by peritubular capillary flow reduction and indirectly by renal function impairment has been documented in early diabetic nephropathy (DN) ass...
